Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HEALTHEQUITY, INC.
Report date November 01, 2021 · Filed November 03, 2021
Section 16 reporting ended · disclosed 2021-11-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,566 |
Reported balance
After 2021-11-01 transaction · row 1
1 source rowRow 1 · 2021-11-01 · Sale · Disposed 1,850 · Balance 30,566 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.44 · Expires 2027-06-21 | Direct | 43,000 |
Reported balance
Holding disclosure · report date 2021-11-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 43,000 F2: The option is immediately exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021.
F2: The option is immediately exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2021 Filed Nov 3, 2021 15:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,850 | $66.42 | $122,877.00 |
DisclosureSEC source: 0001179110-21-009804 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Former Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,566 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 19:25 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,850 | $65.19 | $120,592.44 |
DisclosureSEC source: 0001179110-21-009136 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Former Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,416 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 15:03 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,850 | $65.00 | $120,250.00 |
DisclosureSEC source: 0001179110-21-008565 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Former Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,266 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 19:45 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,850 | $74.47 | $137,768.76 |
DisclosureSEC source: 0001179110-21-007830 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,116 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.01 to $74.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 22:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 1,134 | $77.78 | $88,202.52 |
DisclosureSEC source: 0001179110-21-006953 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,966 Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 15:06 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 1,517 | $67.29 | $102,082.72 |
DisclosureSEC source: 0001179110-21-004278 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,100 F1 · balance_after: The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 15:06 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 1,238 | $67.29 | $83,308.12 |
DisclosureSEC source: 0001179110-21-004278 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,617 Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 704 | $67.50 | $47,521.55 |
DisclosureSEC source: 0001179110-21-003943 · edgar.xml · nonDerivative · entry 3 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,855 F3 · balance_after: The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 4,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-003943 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,559 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 4,113 shares on March 30, 2021. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 20:38 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 4,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-003943 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,446 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units will vest as to 1,244 shares on each of March 30, 2022, 2023 and 2024. The remaining 1,243 shares will vest on March 30, 2025. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 395 | $68.31 | $26,981.50 |
DisclosureSEC source: 0001179110-21-003873 · edgar.xml · nonDerivative · entry 3 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,471 F1 · balance_after: The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 292 | $68.31 | $19,946.49 |
DisclosureSEC source: 0001179110-21-003873 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,866 Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 20:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 151 | $68.31 | $10,315.10 |
DisclosureSEC source: 0001179110-21-003873 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,158 Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 22:35 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,925 | $65.00 | $125,125.00 |
DisclosureSEC source: 0001179110-20-011837 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,309 Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 22:35 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 55 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011837 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,234 Read SEC document |
| June 23, 2020 Filed Jun 24, 2020 20:46 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 928 | $61.12 | $56,719.36 |
DisclosureSEC source: 0001179110-20-007750 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,289 Read SEC document |
| June 10, 2020 Filed Jun 24, 2020 20:46 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007750 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,217 Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:23 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 1,869 | $43.97 | $82,170.96 |
DisclosureSEC source: 0001179110-20-004741 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,307 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 9,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004485 · edgar.xml · nonDerivative · entry 4 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,176 F4 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in four equal installments of 2,306 shares on each of March 31, 2021, 2022, 2023, and 2024. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 4,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004485 · edgar.xml · nonDerivative · entry 3 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,952 F3 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 4,767 shares on March 31, 2020. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004485 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,185 F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 3,019 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:42 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 5,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004485 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,166 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 5,041 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 16:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 299 | $52.22 | $15,612.73 |
DisclosureSEC source: 0001179110-20-004192 · edgar.xml · nonDerivative · entry 4 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,125 Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 16:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 181 | $52.22 | $9,451.04 |
DisclosureSEC source: 0001179110-20-004192 · edgar.xml · nonDerivative · entry 3 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,424 Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 16:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 407 | $55.33 | $22,519.64 |
DisclosureSEC source: 0001179110-20-004192 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,605 Read SEC document |
| July 11, 2019 Filed Mar 30, 2020 16:40 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GiftCommon Stock | 110 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-004192 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,012 Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 20:49 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 758 | $67.65 | $51,278.70 |
DisclosureSEC source: 0001179110-19-008059 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,122 Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 21:16 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 161 | $73.61 | $11,851.21 |
DisclosureSEC source: 0001179110-19-004367 · edgar.xml · nonDerivative · entry 3 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,880 Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 21:16 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 341 | $73.61 | $25,101.01 |
DisclosureSEC source: 0001179110-19-004367 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,041 Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 21:16 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 4,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-004367 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,382 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,132 shares on each of March 27, 2020, 2021, 2022 and 2023. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 22:33 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 764 | $81.36 | $62,159.04 |
DisclosureSEC source: 0001179110-18-009018 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,835 Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 20:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Tax withholdingCommon Stock | 182 | $63.50 | $11,557.00 |
DisclosureSEC source: 0001179110-18-004908 · edgar.xml · nonDerivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,599 Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 20:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 3,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-004908 · edgar.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,781 F1 · shares: Each restricted stock award represents a contingent right to receive one share of the issuer's common stock. The restricted stock awards vest as to 946 shares on March 27, 2019, and in three equal installments of 945 shares on March 27, 2020, 2021 and 2022. Read SEC document |
| June 21, 2017 Filed Jun 24, 2017 01:35 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 43,000 | $0.00 Strike: $51.44 | $0.00 |
DisclosureSEC source: 0001104659-17-041359 · a4.xml · derivative · entry 2 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The option becomes exercisable in four equal annual installments of June 21, 2018, 2019, 2021, and 2022. Read SEC document |
| June 21, 2017 Filed Jun 24, 2017 01:35 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-041359 · a4.xml · nonDerivative · entry 1 Otten William Robert · CIK 0001704840 · Executive VP of Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.